Press-release for stocks for bausch health companies inc. for GSK

| 15.63% | O: 0.63% H: 0.0% C: -2.67%
NVSEF | News | $93.6375 6.88% 82K

| 10.98% | O: 2.5% H: 0.0% C: -0.11%
NVS | News | $92.57 -0.55% 0.0% 910K

| -9.94% | O: 0.13% H: 0.72% C: -0.18%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -16.18% | O: 0.75% H: 1.13% C: -1.05%
GSK | $39.27 -0.83% 0.01% 2.2M

| 12.56% | O: 0.0% H: 0.61% C: -0.28%
BHC | $8.6 -0.69% 0.0% 2.1M

| 1.39% | O: -0.23% H: 1.22% C: -2.21%
ABBV | $164.66 0.25% -0.15% 4.5M

| 8.86% | O: 0.41% H: 1.08% C: 0.16%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -12.41% | O: 1.52% H: 1.05% C: 0.47%
propel treatment global growth market

Nasal Drug Delivery Technology Global Market Report 2023: Major Players Include AptarGroup, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer and 3M
Published: 2023-06-23 (Crawled : 22:00) - prnewswire.com
BHC | $8.6 -0.69% 0.0% 2.1M

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510

| Email alert Add to watchlist
NVS | News | $92.57 -0.55% 0.0% 910K

| Email alert Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M

| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K

| Email alert Add to watchlist
ATR | $139.11 0.51% 0.0% 240K

Process Industries

| Email alert Add to watchlist
BDX | $233.15 0.41% 0.15% 890K

| Email alert Add to watchlist
MDT | News | $79.19 0.14% 0.0% 6.1M

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
drug report global technology market

Global Opioid Induced Constipation Markets to 2030: Revenues, Trends, Competitive Assessment & Intelligence
Published: 2023-06-09 (Crawled : 22:00) - prnewswire.com
BHC | $8.6 -0.69% 0.0% 2.1M

| Email alert Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M

| Email alert Add to watchlist
IRWD | $7.59 -0.78% -0.79% 3.6M

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510

| Email alert Add to watchlist
AZNCF | $140.15 -4.19% 560

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
PFE A | $25.39 -0.12% -0.12% 36M

| Email alert Add to watchlist
TAK | $13.16 0.08% 0.0% 1.3M

| Email alert Add to watchlist
VTRS | $11.11 0.09% 0.09% 3.5M

| Email alert Add to watchlist
opioid global

Non-melanoma Skin Cancer Market size to grow at a CAGR of 5.76% from 2021 to 2026, Driven by the NMSC coverage and support - Technavio
Published: 2023-04-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 8.89% | O: 0.54% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K

| 16.68% | O: 1.25% H: 0.51% C: 0.51%
NVS | News | $92.57 -0.55% 0.0% 910K

| -3.51% | O: 1.3% H: 0.56% C: 0.51%
GSK | $39.27 -0.83% 0.01% 2.2M

| 5.01% | O: 0.85% H: 0.76% C: 0.76%
BHC | $8.6 -0.69% 0.0% 2.1M

| 18.43% | O: 1.49% H: 3.07% C: 0.67%
ICAD | $1.57 0.64% 0.64% 140K

Technology Services

| 5.41% | O: 1.35% H: 0.0% C: -1.33%
AMGN | $262.77 -0.49% -0.49% 2M

| 6.99% | O: -0.36% H: 1.33% C: 1.14%
cancer skin market

Plasma Protease C1 Inhibitor Market size to grow by USD 1.7 billion from 2021 to 2026, Driven by the increasing R&D - Technavio
Published: 2023-04-12 (Crawled : 09:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -12.23% | O: -0.19% H: 0.0% C: 0.0%
CSLLY | $87.96 3.3% 45K

| -12.71% | O: 1.43% H: 0.0% C: -0.7%
GLAXF | $20.2 -14.18% 510

| 8.02% | O: 1.63% H: 0.0% C: -2.39%
NVSEF | News | $93.6375 6.88% 82K

| 17.97% | O: 1.1% H: 0.0% C: 0.0%
NVS | News | $92.57 -0.55% 0.0% 910K

| -2.84% | O: 0.75% H: 0.5% C: -0.05%
GSK | $39.27 -0.83% 0.01% 2.2M

| 6.02% | O: 1.15% H: 0.39% C: -0.19%
BHC | $8.6 -0.69% 0.0% 2.1M

| 14.7% | O: 1.31% H: 0.26% C: -4.4%
ABBV | $164.66 0.25% -0.15% 4.5M

| 1.58% | O: 0.46% H: 0.84% C: 0.15%
KALV | $11.53 -1.03% -1.04% 410K

| 37.54% | O: 0.71% H: 0.0% C: -6.45%
ARGX | $358.65 -2.06% -2.11% 240K

| -1.1% | O: 1.26% H: 0.48% C: 0.04%
market

Ewing's Sarcoma Treatment Market size to grow by USD 302.5 million from 2021 to 2026, Driven by the growing awareness about and funding for Ewing's sarcoma - Technavio
Published: 2023-04-12 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 8.02% | O: 1.63% H: 0.0% C: -2.39%
NVSEF | News | $93.6375 6.88% 82K

| 17.97% | O: 1.1% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M

| 12.01% | O: 0.71% H: 0.3% C: -1.6%
NVS | News | $92.57 -0.55% 0.0% 910K

| -2.84% | O: 0.75% H: 0.5% C: -0.05%
GSK | $39.27 -0.83% 0.01% 2.2M

| 6.02% | O: 1.15% H: 0.39% C: -0.19%
BAX | News | $39.65 0.33% 0.0% 2.3M

| -7.44% | O: 0.47% H: 0.8% C: -0.97%
BHC | $8.6 -0.69% 0.0% 2.1M

| 14.7% | O: 1.31% H: 0.26% C: -4.4%
treatment growing funding market

Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | $262.77 -0.49% -0.49% 2M

| Email alert Add to watchlist
CSLLY | $87.96 3.3% 45K

| Email alert Add to watchlist
MNK | $0.3402 -0.06% 540K

| Email alert Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510

| Email alert Add to watchlist
MNKPF | $17.25

| Email alert Add to watchlist
ABBV | $164.66 0.25% -0.15% 4.5M

| Email alert Add to watchlist
ENDP | $0.2926 -9.6%

| Email alert Add to watchlist
ALPMY | News | $9.46 -1.11% 500K

| Email alert Add to watchlist
VTRS | $11.11 0.09% 0.09% 3.5M

| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K

| Email alert Add to watchlist
UCBJY | $64.07 -4.38% 72K

| Email alert Add to watchlist
NVS | News | $92.57 -0.55% 0.0% 910K

| Email alert Add to watchlist
ALPMF | News | $9.594 43.47% 2.2K

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K

| Email alert Add to watchlist
BHC | $8.6 -0.69% 0.0% 2.1M

| Email alert Add to watchlist
UCBJF | $126.05 -39.66% 100

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
ENDPQ | $0.0006 -50.0% 620K

| Email alert Add to watchlist
CMXHF | $172.54 -19.21% 50

| Email alert Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M

| Email alert Add to watchlist
MNKKQ | $0.02

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M

| Email alert Add to watchlist
NVO | News | $122.75 -1.43% 0.0% 2.8M

| Email alert Add to watchlist
global report

Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K

| -94.35% | O: -1.13% H: 28.57% C: 19.0%
CSLLY | $87.96 3.3% 45K

| -9.95% | O: -3.93% H: 2.17% C: 1.75%
MNK | $0.3402 -0.06% 540K

| -94.75% | O: 3.1% H: 0.0% C: -2.75%
GLAXF | $20.2 -14.18% 510

| 15.53% | O: -0.2% H: 2.06% C: 2.06%
SNYNF | News | $92.7 -2.18% 1.4K

| -3.71% | O: 1.09% H: 0.54% C: 0.54%
UCBJY | $64.07 -4.38% 72K

| 63.03% | O: 1.0% H: 0.0% C: -0.26%
ALPMY | News | $9.46 -1.11% 500K

| -38.39% | O: 3.43% H: 0.0% C: -2.93%
VTRS | $11.11 0.09% 0.09% 3.5M

| -0.27% | O: 0.54% H: 2.5% C: 1.7%
NVO | News | $122.75 -1.43% 0.0% 2.8M

| -7.99% | O: 1.43% H: 0.84% C: -0.23%
NVS | News | $92.57 -0.55% 0.0% 910K

| 2.6% | O: 0.42% H: 1.35% C: 1.22%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -18.05% | O: -0.28% H: 1.26% C: 1.15%
GSK | $39.27 -0.83% 0.01% 2.2M

| 12.69% | O: -0.57% H: 1.35% C: 1.0%
BHC | $8.6 -0.69% 0.0% 2.1M

| 39.17% | O: 0.48% H: 3.96% C: -0.48%
ABBV | $164.66 0.25% -0.15% 4.5M

| 1.43% | O: 0.27% H: 0.6% C: 0.21%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -4.65% | O: 0.16% H: 0.0% C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M

| 1.64% | O: -0.67% H: 0.66% C: 0.3%
pharma global market

Digestive Health Supplements Global Market Report 2022: Ukraine-Russia War Impact
Published: 2022-11-23 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 23.47% | O: 1.83% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| 16.99% | O: -0.53% H: 0.59% C: 0.06%
BHC | $8.6 -0.69% 0.0% 2.1M

| 25.94% | O: -0.29% H: 0.72% C: -2.46%
global report impact health market

Non-melanoma Skin Cancer Market size to grow by USD 180.97 Mn with 36% of the growth to originate from North America - Technavio
Published: 2022-10-19 (Crawled : 11:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K

| 48.61% | O: -1.98% H: 0.0% C: 0.0%
NVS | News | $92.57 -0.55% 0.0% 910K

| 20.12% | O: -0.52% H: 0.06% C: -0.75%
GSK | $39.27 -0.83% 0.01% 2.2M

| 26.72% | O: 0.96% H: 0.22% C: -0.76%
BHC | $8.6 -0.69% 0.0% 2.1M

| 28.72% | O: 0.0% H: 0.0% C: -6.48%
ICAD | $1.57 0.64% 0.64% 140K

Technology Services

| -20.81% | O: -0.51% H: 6.63% C: 1.53%
AMGN | $262.77 -0.49% -0.49% 2M

| 5.88% | O: -0.32% H: 0.41% C: -1.24%
america skin cancer growth market

Global Acne Medication Markets Report 2021-2022 & 2030 Featuring Almirall, Bausch, Galderma, Mayne Pharma, GlaxoSmithKline, Mylan, Pfizer, Johnson & Johnson, Sun Pharma, & Teva
Published: 2022-10-14 (Crawled : 11:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -10.16% | O: 1.93% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| 29.2% | O: 0.59% H: 0.66% C: -0.39%
BHC | $8.6 -0.69% 0.0% 2.1M

| 34.46% | O: 0.46% H: 0.23% C: -1.23%
global report teva acne

USD 45.37 Mn incremental growth expected in Darier Disease Drugs Market -- Driven by an increase in demand for advanced dermatological diagnosis
Published: 2022-09-29 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 33.95% | O: -3.32% H: 4.73% C: 4.73%
NVSEF | News | $93.6375 6.88% 82K

| 51.07% | O: 1.87% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M

| 27.15% | O: -1.26% H: 0.7% C: -0.23%
NVS | News | $92.57 -0.55% 0.0% 910K

| 21.96% | O: 0.17% H: 1.1% C: 0.16%
GSK | $39.27 -0.83% 0.01% 2.2M

| 34.42% | O: -0.14% H: 0.53% C: -0.2%
BHC | $8.6 -0.69% 0.0% 2.1M

| 17.0% | O: -1.2% H: 0.0% C: -5.83%
ABBV | $164.66 0.25% -0.15% 4.5M

| 13.36% | O: 0.17% H: 0.28% C: -1.47%
disease expected dermatological growth market

Macular Degeneration Treatment Global Market to Reach $10.65 Billion by 2026 at a CAGR of 7.15%
Published: 2022-09-14 (Crawled : 10:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 31.38% | O: -4.98% H: 7.63% C: 2.67%
NVS | News | $92.57 -0.55% 0.0% 910K

| 13.58% | O: -0.55% H: 0.42% C: -0.72%
GSK | $39.27 -0.83% 0.01% 2.2M

| 25.2% | O: -0.6% H: 0.41% C: -0.76%
BHC | $8.6 -0.69% 0.0% 2.1M

| 18.75% | O: 0.41% H: 11.64% C: 6.22%
RGNX | News | $16.08 -5.58% -5.91% 560K

| -35.32% | O: 0.38% H: 2.53% C: 1.48%
treatment global macular market

Global Treatment Resistant Depression Market to Surpass US$ 1,545.6 Million by 2030 - Coherent Market Insights
Published: 2022-09-05 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 27.81% | O: 0.6% H: 0.0% C: -4.59%
SNYNF | News | $92.7 -2.18% 1.4K

| 18.0% | O: -2.93% H: 10.14% C: 3.79%
ATAI | News | $1.91 -3.54% -3.66% 1M

| -50.57% | O: 1.61% H: 0.45% C: -4.97%
VTRS | $11.11 0.09% 0.09% 3.5M

| 17.46% | O: 0.42% H: 0.0% C: -0.84%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -12.68% | O: -1.1% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| 24.33% | O: -0.63% H: 0.35% C: -0.57%
LLY | News | $745.95 -0.64% -0.1% 1.7M

| 149.15% | O: 0.54% H: 3.26% C: 1.28%
BHC | $8.6 -0.69% 0.0% 2.1M

| 35.5% | O: 0.47% H: 1.39% C: 0.15%
ABBV | $164.66 0.25% -0.15% 4.5M

| 20.29% | O: 0.75% H: 1.49% C: 0.21%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| 14.19% | O: -1.35% H: 0.0% C: 0.0%
treatment global depression market

Anti-obesity Drugs Market Size to Grow by USD 454.51 million | Growing Obese Population to Boost Market Growth | 17,000+ Technavio Research Reports
Published: 2022-07-06 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| -21.71% | O: -0.73% H: 1.02% C: 1.02%
GSK | $39.27 -0.83% 0.01% 2.2M

| -26.84% | O: -0.51% H: 0.73% C: 0.07%
BHC | $8.6 -0.69% 0.0% 2.1M

| -3.43% | O: -0.77% H: 1.61% C: -4.45%
RYTM A | $38.11 -0.88% -0.89% 440K

| 773.86% | O: 0.45% H: 8.37% C: 7.24%
research growing growth market obesity

Herpes Treatment Market size to grow by USD 723.04 Mn | Market Research Insights highlight increasing prevalence of herpes infection as Key Driver | Technavio
Published: 2022-06-29 (Crawled : 04:00) - prnewswire.com
TEVJF | $12.37 -24.22% 380

| 48.32% | O: -9.17% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510

| -26.51% | O: -0.95% H: 1.01% C: -3.54%
VTRS | $11.11 0.09% 0.09% 3.5M

| -0.05% | O: -1.49% H: 0.09% C: -1.19%
NVS | News | $92.57 -0.55% 0.0% 910K

| 8.98% | O: -0.68% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| -26.92% | O: 0.3% H: 1.08% C: 0.67%
BHC | $8.6 -0.69% 0.0% 2.1M

| -0.11% | O: 0.57% H: 0.57% C: -3.3%
treatment research infection market

The Worldwide Herpes Zoster Treatment Industry is Expected to Reach $303.4 Million by 2030
Published: 2022-06-20 (Crawled : 16:00) - prnewswire.com
BHC | $8.6 -0.69% 0.0% 2.1M

| Email alert Add to watchlist
PPRUY | News | $36.03 -0.11% 330K

| Email alert Add to watchlist
ABT | News | $105.27 -0.6% -0.15% 7.3M

| Email alert Add to watchlist
PPRUF | News | $361.9 37.56% 4.3K

Consumer Non-Durables

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M

| Email alert Add to watchlist
LLY | News | $745.95 -0.64% -0.1% 1.7M

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510

| Email alert Add to watchlist
treatment expected

Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published: 2022-05-18 (Crawled : 07:00) - prnewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K

| 5.63% | O: -0.31% H: 0.53% C: -0.19%
GSK | $39.27 -0.83% 0.01% 2.2M

| -11.15% | O: -0.43% H: 0.0% C: 0.0%
BHC | $8.6 -0.69% 0.0% 2.1M

| -20.9% | O: -0.72% H: 1.09% C: -9.3%
ABBV | $164.66 0.25% -0.15% 4.5M

| 5.72% | O: -0.17% H: 0.59% C: -1.52%
ACAD | News | $17.08 -0.64% -0.64% 990K

| 0.17% | O: -3.61% H: 1.39% C: -3.14%
europe disease growth market

The Worldwide Dermatology OTC Medications Industry is Expected to Reach $21.3 Billion by 2028
Published: 2022-05-16 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| -23.74% | O: 3.12% H: 0.01% C: -0.23%
VTRS | $11.11 0.09% 0.09% 3.5M

| 0.18% | O: 0.18% H: 0.0% C: 0.0%
PRGO | $29.94 -0.33% 0.0% 970K

| -18.3% | O: 0.08% H: 2.15% C: 1.49%
GSK | $39.27 -0.83% 0.01% 2.2M

| -8.59% | O: 1.15% H: 0.0% C: 0.0%
BHC | $8.6 -0.69% 0.0% 2.1M

| -17.08% | O: 1.99% H: 0.0% C: 0.0%
expected

Dementia and Movement Disorder Treatment Market: 45% of Growth to Originate from North America | By Drug Class and Geography - Forecast and Analysis 2022-2026
Published: 2022-05-11 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K

| 33.69% | O: 0.81% H: 0.0% C: -0.09%
NVS | News | $92.57 -0.55% 0.0% 910K

| 10.11% | O: 0.27% H: 1.2% C: -0.85%
GSK | $39.27 -0.83% 0.01% 2.2M

| -8.55% | O: -0.65% H: 1.14% C: -1.14%
BHC | $8.6 -0.69% 0.0% 2.1M

| 8.84% | O: 15.69% H: 13.62% C: 9.04%
ABBV | $164.66 0.25% -0.15% 4.5M

| 8.29% | O: 0.21% H: 0.0% C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M